Navigation Links
Kosan Announces Third Quarter 2007 Financial Results

r to

evaluate the safety and anticancer activity of alvespimycin as a single


-- Kosan presented updated Phase 1 data on KOS-1584 at the 2007 Annual

Meeting of the American Association for Cancer Research/National Cancer

Institute/European Organization for Research and Treatment of Cancer

(AACR/NCI/EORTC) showing that KOS-1584 was well-tolerated and

demonstrated antitumor activity in ovarian, non-small cell lung,

breast, pancreatic and prostate cancers.

-- Kosan hosted its first Kosan Research and Development Day in New York,

highlighting Kosan's leadership in Hsp90 inhibitor therapeutics,

clinical progress, regulatory strategies and future pipeline


Conference Call and Webcast Today

Kosan will hold a conference call to discuss its financial results for the quarter and nine months ended September 30, 2007 and provide an update on its business today at 1:30 p.m. Pacific / 4:30 p.m. Eastern. To access the live call, please dial 866.510.0707 (US) or 617.597.5376 (international), access code 93636825. Interested parties may listen to the webcast live at by clicking on the "Webcasts" tab under the heading "Investors/Press." The webcast is also being distributed over Thomson's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson's individual investor center at or by visiting any of the investor sites in Thomson's Individual Investor Network. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents, at A telephonic replay will be available through November 15, 2007 by dialin

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Kosan Biosciences to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Kosan Biosciences to Present at the 2007 UBS Global Life Sciences Conference
3. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
4. Kosan Biosciences to Host Research & Development Day on October 31, 2007
5. Kosan to Reacquire Epothilone Program From Roche
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
(Date:10/8/2015)... Oct. 8, 2015  Today, DuPont and Caribou ... genome editing, jointly announced a strategic alliance. As ... their respective patent portfolios, with DuPont receiving exclusive ... major row crops, and non-exclusive rights in other ... --> --> In addition, ...
(Date:10/8/2015)... ... 2015 , ... Talon Innovations, a provider of Precision Machined Products ... it is one of three finalists for the Minnesota Business magazine’s Manufacturing Award in ... Talon Innovations was recognized as a nominee for this competitive award. , The ...
(Date:10/7/2015)... ... ... Neil Riordan, PhD to Discuss Medicinal Effects of Mesenchymal Stem Cells and Their Secretions ... 4:30 pm. , Dr. Riordan is one of the early pioneers and leading experts ... Chief Science Officer of the Riordan-McKenna Institute of Regenerative Orthopedics in Southlake, ...
(Date:10/7/2015)... , Oct. 7, 2015  October is National Liver Awareness ... committed to donating a portion of its October profits ... hepatology practices. ... a variety of ways; whether it is by providing ... collaborating with researchers in different disease and investigation areas, ...
Breaking Biology Technology:
... - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced ... a clinical trial using intravenous administration of,REOLYSIN(R) ... well as immune modulator, in patients with ... Spicer of King,s College in London,Dr. Johann ...
... (Nasdaq:,ATSI), manufacturer and marketer of state-of-the-art cardiac surgery,products, ... Rodman & Renshaw,5th Annual Global Healthcare Conference at ... on Tuesday, May 20, 2008. Michael Dale, President ... a.m. local time., (Logo: ), ...
... Inc. (OTC,Bulletin Board: PLMO) announced today that it ... taking its total holdings to 61% in this ... for pulmonary,related medical conditions., Pulmo BioTech CEO ... technology, developed and owned by PulmoScience, will dominate ...
Cached Biology Technology:
(Date:9/30/2015)... 30, 2015  With nearly 300,000 Americans living with ... SCIs estimated to reach 12,500 annually, the role of ... Services for Independent Living (SCRS-IL) is increasingly important. ... California opening doors to independence for individuals ... services, notably assistive technology services and education. ...
(Date:9/29/2015)... 2015  iDAvatars is excited to be named one of ... market. The official announcement was recently made at an invite-only ... San Francisco , where iDAvatars presented a ... Watson. "It is both an honor and a ... bring to market the cognitive power of IBM Watson in ...
(Date:9/28/2015)... -- According to a new market research ... & Others), Application (Access Control & Others), Industry (Travel ... Global - Forecast to 2020", published by MarketsandMarkets, the Iris ... by 2020, at a CAGR of 23.40% between 2015 ... T ables and 66 Figures spread ...
Breaking Biology News(10 mins):
... nice piece of certified sustainable fish at the supermarket, you,d ... aren,t always what they seem, according to researchers who have ... report their findings in the August 23 issue of ... found that, for fish purchased in US groceries, not all ...
... 2011, 3:00 PM U.S. EASTERN TIME) A study ... Sciences (PNAS) documents the success of a Wildlife ... to improve rural livelihoods while restoring local wildlife populations., ... began in Zambia in 2003 and has resulted in ...
... Research (ONR) will share partnership possibilities with members of ... Gold Coast Small Business Opportunity Conference, being held Aug. ... to identify potential program participants from among the 1,500 ... Small Business Programs. "The event is a great way ...
Cached Biology News:
... of the smallest thermal cyclers on the market, ... the 0.5ml (20 samples) or 0.2ml microtube (25 ... heating and cooling rate of 3.6C/sec and 2.0C/sec ... Fast track programming with new quick dial ...
... an aqueous solution that contains a purified ... in a MOPS buffer (3-(N-Morpholino) propanesulfonic acid), ... contains a combination of 0.02% methylisothiazolone, 0.02% ... and Haas Company) as a preservative. ...
Preparation Note: Prepared by method of Wimmer, E., et al., Biochemistry, 7, 2623 (1968). Quality Clarifier: Acceptor Activity: approx. 1000 picomoles phenylalanine per A 260 unit (not determined b...
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin...
Biology Products: